Sequenom Inc. completed its acquisition of Axiom Biotechnologies Inc., paving the way to fold Axiom's cell biology program into Sequenom's gene discovery business. (Bioworld Today)

Sequenom Completes Axiom Purchase, Gains Cell Biology

Sep. 4, 2002

By Karen Young

Sequenom Inc. completed its acquisition of Axiom Biotechnologies Inc., paving the way to fold Axiom's cell biology program into Sequenom's gene discovery business. (Bioworld Today)

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...